Logo image of CTRE

CARETRUST REIT INC (CTRE) Stock Fundamental Analysis

NYSE:CTRE - US14174T1079 - REIT

33.94 USD
-0.14 (-0.41%)
Last: 9/5/2025, 8:06:18 PM
33.94 USD
0 (0%)
After Hours: 9/5/2025, 8:06:18 PM
Fundamental Rating

7

Overall CTRE gets a fundamental rating of 7 out of 10. We evaluated CTRE against 129 industry peers in the Diversified REITs industry. CTRE has an excellent profitability rating, but there are some minor concerns on its financial health. CTRE is growing strongly while it is still valued neutral. This is a good combination! This makes CTRE very considerable for growth investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CTRE had positive earnings in the past year.
In the past year CTRE had a positive cash flow from operations.
Of the past 5 years CTRE 4 years were profitable.
In the past 5 years CTRE always reported a positive cash flow from operatings.
CTRE Yearly Net Income VS EBIT VS OCF VS FCFCTRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

With an excellent Return On Assets value of 4.71%, CTRE belongs to the best of the industry, outperforming 92.25% of the companies in the same industry.
The Return On Equity of CTRE (6.64%) is better than 77.52% of its industry peers.
With an excellent Return On Invested Capital value of 4.38%, CTRE belongs to the best of the industry, outperforming 80.62% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CTRE is above the industry average of 3.04%.
Industry RankSector Rank
ROA 4.71%
ROE 6.64%
ROIC 4.38%
ROA(3y)1.9%
ROA(5y)3.08%
ROE(3y)2.37%
ROE(5y)4.75%
ROIC(3y)5.24%
ROIC(5y)5.34%
CTRE Yearly ROA, ROE, ROICCTRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

The Profit Margin of CTRE (58.73%) is better than 97.67% of its industry peers.
In the last couple of years the Profit Margin of CTRE has grown nicely.
CTRE has a better Operating Margin (66.50%) than 99.22% of its industry peers.
CTRE's Operating Margin has improved in the last couple of years.
CTRE has a Gross Margin of 98.44%. This is amongst the best in the industry. CTRE outperforms 98.45% of its industry peers.
Industry RankSector Rank
OM 66.5%
PM (TTM) 58.73%
GM 98.44%
OM growth 3Y5.41%
OM growth 5Y3.45%
PM growth 3Y4.22%
PM growth 5Y8.32%
GM growth 3YN/A
GM growth 5YN/A
CTRE Yearly Profit, Operating, Gross MarginsCTRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CTRE is destroying value.
The number of shares outstanding for CTRE has been increased compared to 1 year ago.
The number of shares outstanding for CTRE has been increased compared to 5 years ago.
The debt/assets ratio for CTRE has been reduced compared to a year ago.
CTRE Yearly Shares OutstandingCTRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CTRE Yearly Total Debt VS Total AssetsCTRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

CTRE has an Altman-Z score of 3.48. This indicates that CTRE is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 3.48, CTRE belongs to the best of the industry, outperforming 98.45% of the companies in the same industry.
CTRE has a Debt/Equity ratio of 0.35. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.35, CTRE belongs to the top of the industry, outperforming 96.12% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Altman-Z 3.48
ROIC/WACC0.52
WACC8.48%
CTRE Yearly LT Debt VS Equity VS FCFCTRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

CTRE has a Current Ratio of 1.75. This is a normal value and indicates that CTRE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.75, CTRE is in the better half of the industry, outperforming 74.42% of the companies in the same industry.
CTRE has a Quick Ratio of 1.75. This is a normal value and indicates that CTRE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.75, CTRE is in the better half of the industry, outperforming 74.42% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.75
CTRE Yearly Current Assets VS Current LiabilitesCTRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

9

3. Growth

3.1 Past

CTRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 108.47%, which is quite impressive.
CTRE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.30% yearly.
The Revenue has grown by 50.83% in the past year. This is a very strong growth!
CTRE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.64% yearly.
EPS 1Y (TTM)108.47%
EPS 3Y-1.19%
EPS 5Y11.3%
EPS Q2Q%400%
Revenue 1Y (TTM)50.83%
Revenue growth 3Y15.48%
Revenue growth 5Y12.64%
Sales Q2Q%102.99%

3.2 Future

The Earnings Per Share is expected to grow by 23.02% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 27.83% on average over the next years. This is a very strong growth
EPS Next Y75.18%
EPS Next 2Y36.67%
EPS Next 3Y23.02%
EPS Next 5YN/A
Revenue Next Year39.08%
Revenue Next 2Y33.46%
Revenue Next 3Y27.83%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CTRE Yearly Revenue VS EstimatesCTRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
CTRE Yearly EPS VS EstimatesCTRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

CTRE is valuated quite expensively with a Price/Earnings ratio of 27.59.
68.22% of the companies in the same industry are more expensive than CTRE, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.06. CTRE is around the same levels.
A Price/Forward Earnings ratio of 22.16 indicates a rather expensive valuation of CTRE.
Based on the Price/Forward Earnings ratio, CTRE is valued cheaper than 91.47% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.69. CTRE is around the same levels.
Industry RankSector Rank
PE 27.59
Fwd PE 22.16
CTRE Price Earnings VS Forward Price EarningsCTRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

CTRE's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. CTRE is more expensive than 92.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 26.58
CTRE Per share dataCTRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

CTRE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of CTRE may justify a higher PE ratio.
CTRE's earnings are expected to grow with 23.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.37
PEG (5Y)2.44
EPS Next 2Y36.67%
EPS Next 3Y23.02%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.93%, CTRE has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 6.63, CTRE is paying slightly less dividend.
CTRE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 3.93%

5.2 History

The dividend of CTRE has a limited annual growth rate of 4.05%.
CTRE has paid a dividend for at least 10 years, which is a reliable track record.
CTRE has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)4.05%
Div Incr Years9
Div Non Decr Years9
CTRE Yearly Dividends per shareCTRE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

CTRE pays out 96.62% of its income as dividend. This is not a sustainable payout ratio.
The dividend of CTRE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP96.62%
EPS Next 2Y36.67%
EPS Next 3Y23.02%
CTRE Yearly Income VS Free CF VS DividendCTRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M
CTRE Dividend Payout.CTRE Dividend Payout, showing the Payout Ratio.CTRE Dividend Payout.PayoutRetained Earnings

CARETRUST REIT INC

NYSE:CTRE (9/5/2025, 8:06:18 PM)

After market: 33.94 0 (0%)

33.94

-0.14 (-0.41%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners99.71%
Inst Owner Change8.33%
Ins Owners0.54%
Ins Owner Change1.14%
Market Cap7.58B
Analysts87.14
Price Target36.08 (6.31%)
Short Float %3.22%
Short Ratio2.78
Dividend
Industry RankSector Rank
Dividend Yield 3.93%
Yearly Dividend1.09
Dividend Growth(5Y)4.05%
DP96.62%
Div Incr Years9
Div Non Decr Years9
Ex-Date06-30 2025-06-30 (0.335)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.16%
Min EPS beat(2)-6.76%
Max EPS beat(2)0.43%
EPS beat(4)2
Avg EPS beat(4)-8.38%
Min EPS beat(4)-29.49%
Max EPS beat(4)2.3%
EPS beat(8)2
Avg EPS beat(8)-24.52%
EPS beat(12)2
Avg EPS beat(12)-38.92%
EPS beat(16)4
Avg EPS beat(16)-30.02%
Revenue beat(2)1
Avg Revenue beat(2)9.81%
Min Revenue beat(2)-15.93%
Max Revenue beat(2)35.56%
Revenue beat(4)2
Avg Revenue beat(4)10.79%
Min Revenue beat(4)-15.93%
Max Revenue beat(4)35.56%
Revenue beat(8)4
Avg Revenue beat(8)5.96%
Revenue beat(12)7
Avg Revenue beat(12)4.33%
Revenue beat(16)8
Avg Revenue beat(16)2.79%
PT rev (1m)6.48%
PT rev (3m)11.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.85%
EPS NY rev (1m)0.6%
EPS NY rev (3m)-5.06%
Revenue NQ rev (1m)2.5%
Revenue NQ rev (3m)4.57%
Revenue NY rev (1m)1.45%
Revenue NY rev (3m)1.33%
Valuation
Industry RankSector Rank
PE 27.59
Fwd PE 22.16
P/S 20.3
P/FCF N/A
P/OCF 24.09
P/B 2.3
P/tB 2.3
EV/EBITDA 26.58
EPS(TTM)1.23
EY3.62%
EPS(NY)1.53
Fwd EY4.51%
FCF(TTM)-5.04
FCFYN/A
OCF(TTM)1.41
OCFY4.15%
SpS1.67
BVpS14.78
TBVpS14.78
PEG (NY)0.37
PEG (5Y)2.44
Profitability
Industry RankSector Rank
ROA 4.71%
ROE 6.64%
ROCE 5.54%
ROIC 4.38%
ROICexc 4.7%
ROICexgc 4.7%
OM 66.5%
PM (TTM) 58.73%
GM 98.44%
FCFM N/A
ROA(3y)1.9%
ROA(5y)3.08%
ROE(3y)2.37%
ROE(5y)4.75%
ROIC(3y)5.24%
ROIC(5y)5.34%
ROICexc(3y)5.66%
ROICexc(5y)5.62%
ROICexgc(3y)5.66%
ROICexgc(5y)5.62%
ROCE(3y)6.63%
ROCE(5y)6.75%
ROICexcg growth 3Y-3.12%
ROICexcg growth 5Y0.18%
ROICexc growth 3Y-3.12%
ROICexc growth 5Y0.18%
OM growth 3Y5.41%
OM growth 5Y3.45%
PM growth 3Y4.22%
PM growth 5Y8.32%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Debt/EBITDA 3.64
Cap/Depr 2097.02%
Cap/Sales 385.9%
Interest Coverage 8.55
Cash Conversion 99.23%
Profit Quality N/A
Current Ratio 1.75
Quick Ratio 1.75
Altman-Z 3.48
F-Score5
WACC8.48%
ROIC/WACC0.52
Cap/Depr(3y)658.62%
Cap/Depr(5y)503.99%
Cap/Sales(3y)134.69%
Cap/Sales(5y)112.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)108.47%
EPS 3Y-1.19%
EPS 5Y11.3%
EPS Q2Q%400%
EPS Next Y75.18%
EPS Next 2Y36.67%
EPS Next 3Y23.02%
EPS Next 5YN/A
Revenue 1Y (TTM)50.83%
Revenue growth 3Y15.48%
Revenue growth 5Y12.64%
Sales Q2Q%102.99%
Revenue Next Year39.08%
Revenue Next 2Y33.46%
Revenue Next 3Y27.83%
Revenue Next 5YN/A
EBIT growth 1Y56.55%
EBIT growth 3Y21.72%
EBIT growth 5Y16.53%
EBIT Next Year178.37%
EBIT Next 3Y54.56%
EBIT Next 5Y39.97%
FCF growth 1Y-2758.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y119.86%
OCF growth 3Y15.9%
OCF growth 5Y14.1%